Nipro Overview

  • Founded
  • 1954

Founded
  • Status
  • Public

  • Employees
  • 37,235

Employees
  • Stock Symbol
  • 8086

Stock Symbol
  • Investments
  • 24

  • Share Price
  • $8.01

  • (As of Tuesday Closing)

Nipro General Information

Description

Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Contact Information

Website
www.nipro.co.jp
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Medical Supplies
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • 3-9-3 Honjo-Nishi Kita-ku
  • Osaka, 531-8510
  • Japan
+81 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nipro Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.01 $8.03 $7.43 - $12.78 $1.31B 163M 393K $0.73

Nipro Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 5,658,229 5,658,229 6,772,230 6,174,147
Revenue 4,404,261 4,404,261 4,296,125 4,069,768
EBITDA 648,664 648,664 598,598 315,214
Net Income 119,767 119,767 133,997 (112,947)
Total Assets 7,622,585 7,622,585 7,745,014 7,697,247
Total Debt 4,628,115 4,628,115 4,942,936 5,008,834
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nipro Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nipro‘s full profile, request access.

Request a free trial

Nipro Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in f
Medical Supplies
Osaka, Japan
37,235 As of 2022
00000000

000000

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore ma
0000000 00000000
Tokyo, Japan
00000 As of 0000
00000000

0000 0

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
0000000 00000000
Exton, PA
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nipro Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Terumo Corporation Tokyo, Japan 00000 00000000
0000 0000000000000 Corporation Exton, PA 00000 00000000
000000000000000 00 Corporation Lagos, Nigeria 00
00000000 000000 00 Corporation Weihai, China 00000 00000 000000 - 000 00000
000000 0000000 Corporation Kobe, Japan 0000 00000000
You’re viewing 5 of 13 competitors. Get the full list »

Nipro Patents

Nipro Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210383531-A1 Foreign matter inspection system and foreign matter inspection method Pending 31-Oct-2018 0000000000
DE-102018006961-A1 Hollow glass body and use of a hollow glass body Pending 03-Sep-2018 000000000
DE-102018006968-A1 Method for separating a hollow glass body from a glass tube and method and system for producing a container Pending 03-Sep-2018 000000000
EP-3847137-A1 Hollow glass body and use of a hollow glass body Pending 03-Sep-2018 000000000
EP-3847138-A1 Method for separating a hollow glass body from a glass tube as well as method and system for manufacturing a receptacle Pending 03-Sep-2018 A61J1/065
To view Nipro’s complete patent history, request access »

Nipro Executive Team (5)

Name Title Board Seat Contact Info
Yoshihiko Sano Board Member & President
Kiyotaka Yoshioka Board Member & General Manager
Kyoetsu Kobayashi Board Member & General Manager
Toshiaki Masuda Board Member & General Manager
You’re viewing 4 of 5 executive team members. Get the full list »

Nipro Board Members (5)

Name Representing Role Since
000000 00000000 Nipro Board Member 000 0000
00000000 00000000 Nipro Board Member & General Manager 000 0000
0000000 000000000 Nipro Board Member & General Manager 000 0000
00000000 000000 Nipro Board Member & General Manager 000 0000
000000000 0000 Nipro Board Member & President 000 0000
To view Nipro’s complete board members history, request access »

Nipro Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nipro Investments & Acquisitions (24)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (000 03-Apr-2021 0000000000 Other Containers and Packaging 000000000
000000 000000 28-Oct-2020 0000 00000 00.00 Therapeutic Devices 00000000
0000000 000 03-Mar-2020 0000000000 Specialty Chemicals 000000 00
000000000 000 01-Jan-2018 0000000000 Surgical Devices
TC Biopharm 18-Jan-2017 Early Stage VC 00.000 Drug Discovery
You’re viewing 5 of 24 investments and acquisitions. Get the full list »

Nipro Subsidiaries (8)

Company Name Industry Location Founded
Dimesol USA Specialty Chemicals Lewisberry, PA 2016
0000 0000000 & 000 Biotechnology Aoba-ku, Japan 0000
000000000 Diagnostic Equipment Burlington, MA 0000
00000 000000 Mechelen, Belgium 0000
00000000 (0000000) Other Containers and Packaging Sesvete, Croatia 0000
You’re viewing 5 of 8 subsidiaries. Get the full list »

Nipro Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 000000 15-Mar-2010 000000000000000000 00000 Completed
  • 00000
000000000 07-Oct-2008 00000 00000 00 00.000 Completed
  • 5 buyers
Bipha 01-Feb-2001 Secondary Transaction - Private Completed
To view Nipro’s complete exits history, request access »